$GEB Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in INOVIO PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in INOVIO PHARMACEUTICALS, INC.. Get notifications about new insider transactions in INOVIO PHARMACEUTICALS, INC. for free.
Page: < prev 1 2 3 4 5 6 ... 6 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 12 2020 | GEB | INOVIO PHARMACEUTI ... | Humeau Laurent | Chief Scientific Of ... | Buy | M | 0.00 | 2,812 | 0 | 83,873 | 81.1 K to 83.9 K (+3.47 %) |
Mar 12 2020 | GEB | INOVIO PHARMACEUTI ... | Humeau Laurent | Chief Scientific Of ... | Option Exercise | A | 0.00 | 179,211 | 0 | 179,211 | |
Mar 12 2020 | GEB | INOVIO PHARMACEUTI ... | Humeau Laurent | Chief Scientific Of ... | Option Exercise | M | 0.00 | 2,812 | 0 | 0 | |
Mar 12 2020 | GEB | INOVIO PHARMACEUTI ... | Humeau Laurent | Chief Scientific Of ... | Payment of Exercise | F | 5.70 | 973 | 5,546 | 82,900 | 83.9 K to 82.9 K (-1.16 %) |
Mar 12 2020 | GEB | INOVIO PHARMACEUTI ... | Humeau Laurent | Chief Scientific Of ... | Buy | M | 0.00 | 2,812 | 0 | 83,873 | 81.1 K to 83.9 K (+3.47 %) |
Mar 12 2020 | GEB | INOVIO PHARMACEUTI ... | KIES PETER | CFO | Option Exercise | A | 0.00 | 179,211 | 0 | 179,211 | |
Mar 12 2020 | GEB | INOVIO PHARMACEUTI ... | KIES PETER | CFO | Option Exercise | M | 0.00 | 20,433 | 0 | 0 | |
Mar 12 2020 | GEB | INOVIO PHARMACEUTI ... | KIES PETER | CFO | Payment of Exercise | F | 5.70 | 7,066 | 40,276 | 154,290 | 161.4 K to 154.3 K (-4.38 %) |
Mar 12 2020 | GEB | INOVIO PHARMACEUTI ... | KIES PETER | CFO | Buy | M | 0.00 | 20,433 | 0 | 161,356 | 140.9 K to 161.4 K (+14.50 %) |
Mar 12 2020 | GEB | INOVIO PHARMACEUTI ... | KIES PETER | CFO | Option Exercise | A | 0.00 | 179,211 | 0 | 179,211 | |
Mar 12 2020 | GEB | INOVIO PHARMACEUTI ... | KIES PETER | CFO | Option Exercise | M | 0.00 | 20,433 | 0 | 0 | |
Mar 12 2020 | GEB | INOVIO PHARMACEUTI ... | KIES PETER | CFO | Payment of Exercise | F | 5.70 | 7,066 | 40,276 | 154,290 | 161.4 K to 154.3 K (-4.38 %) |
Mar 12 2020 | GEB | INOVIO PHARMACEUTI ... | KIES PETER | CFO | Buy | M | 0.00 | 20,433 | 0 | 161,356 | 140.9 K to 161.4 K (+14.50 %) |
Mar 12 2020 | GEB | INOVIO PHARMACEUTI ... | Weiner David B. | Director | Option Exercise | A | 8.37 | 60,000 | 502,200 | 60,000 | |
Mar 12 2020 | GEB | INOVIO PHARMACEUTI ... | Weiner David B. | Director | Option Exercise | A | 0.00 | 35,000 | 0 | 35,000 | |
Mar 12 2020 | GEB | INOVIO PHARMACEUTI ... | Weiner David B. | Director | Option Exercise | M | 0.00 | 11,666 | 0 | 0 | |
Mar 12 2020 | GEB | INOVIO PHARMACEUTI ... | Weiner David B. | Director | Sell | S | 11.14 | 3,500 | 38,990 | 821,610 | 825.1 K to 821.6 K (-0.42 %) |
Mar 12 2020 | GEB | INOVIO PHARMACEUTI ... | Weiner David B. | Director | Sell | S | 9.32 | 3,500 | 32,620 | 825,110 | 828.6 K to 825.1 K (-0.42 %) |
Mar 12 2020 | GEB | INOVIO PHARMACEUTI ... | Weiner David B. | Director | Buy | M | 0.00 | 11,666 | 0 | 828,610 | 816.9 K to 828.6 K (+1.43 %) |
Mar 09 2020 | GEB | INOVIO PHARMACEUTI ... | Weiner David B. | Director | Option Exercise | M | 0.00 | 11,667 | 0 | 23,333 | |
Mar 09 2020 | GEB | INOVIO PHARMACEUTI ... | Weiner David B. | Director | Option Exercise | M | 0.00 | 11,667 | 0 | 11,666 | |
Mar 09 2020 | GEB | INOVIO PHARMACEUTI ... | Weiner David B. | Director | Sell | S | 18.00 | 3,500 | 63,000 | 816,944 | 820.4 K to 816.9 K (-0.43 %) |
Mar 09 2020 | GEB | INOVIO PHARMACEUTI ... | Weiner David B. | Director | Buy | M | 0.00 | 11,667 | 0 | 820,444 | 808.8 K to 820.4 K (+1.44 %) |
Mar 09 2020 | GEB | INOVIO PHARMACEUTI ... | Weiner David B. | Director | Buy | M | 0.00 | 11,667 | 0 | 808,777 | 797.1 K to 808.8 K (+1.46 %) |
Mar 09 2020 | GEB | INOVIO PHARMACEUTI ... | Kim Jong Joseph | Chief Executive Off ... | Option Exercise | M | 0.00 | 63,700 | 0 | 127,400 | |
Mar 09 2020 | GEB | INOVIO PHARMACEUTI ... | Kim Jong Joseph | Chief Executive Off ... | Option Exercise | M | 0.00 | 120,100 | 0 | 120,100 | |
Mar 09 2020 | GEB | INOVIO PHARMACEUTI ... | Kim Jong Joseph | Chief Executive Off ... | Payment of Exercise | F | 14.09 | 27,697 | 390,251 | 1,219,439 | 1.2 M to 1.2 M (-2.22 %) |
Mar 09 2020 | GEB | INOVIO PHARMACEUTI ... | Kim Jong Joseph | Chief Executive Off ... | Buy | M | 0.00 | 63,700 | 0 | 1,247,136 | 1.2 M to 1.2 M (+5.38 %) |
Mar 09 2020 | GEB | INOVIO PHARMACEUTI ... | Kim Jong Joseph | Chief Executive Off ... | Payment of Exercise | F | 9.80 | 37,371 | 366,236 | 1,183,436 | 1.2 M to 1.2 M (-3.06 %) |
Mar 09 2020 | GEB | INOVIO PHARMACEUTI ... | Kim Jong Joseph | Chief Executive Off ... | Buy | M | 0.00 | 120,100 | 0 | 1,220,807 | 1.1 M to 1.2 M (+10.91 %) |
Mar 09 2020 | GEB | INOVIO PHARMACEUTI ... | Humeau Laurent | Chief Scientific Of ... | Option Exercise | M | 0.00 | 19,900 | 0 | 39,800 | |
Mar 09 2020 | GEB | INOVIO PHARMACEUTI ... | Humeau Laurent | Chief Scientific Of ... | Option Exercise | M | 0.00 | 27,567 | 0 | 27,566 | |
Mar 09 2020 | GEB | INOVIO PHARMACEUTI ... | Humeau Laurent | Chief Scientific Of ... | Payment of Exercise | F | 14.09 | 6,882 | 96,967 | 81,061 | 87.9 K to 81.1 K (-7.83 %) |
Mar 09 2020 | GEB | INOVIO PHARMACEUTI ... | Humeau Laurent | Chief Scientific Of ... | Buy | M | 0.00 | 19,900 | 0 | 87,943 | 68 K to 87.9 K (+29.25 %) |
Mar 09 2020 | GEB | INOVIO PHARMACEUTI ... | Humeau Laurent | Chief Scientific Of ... | Payment of Exercise | F | 9.80 | 9,857 | 96,599 | 68,043 | 77.9 K to 68 K (-12.65 %) |
Mar 09 2020 | GEB | INOVIO PHARMACEUTI ... | Humeau Laurent | Chief Scientific Of ... | Buy | M | 0.00 | 27,567 | 0 | 77,900 | 50.3 K to 77.9 K (+54.77 %) |
Mar 09 2020 | GEB | INOVIO PHARMACEUTI ... | KIES PETER | CFO | Option Exercise | M | 0.00 | 21,467 | 0 | 42,933 | |
Mar 09 2020 | GEB | INOVIO PHARMACEUTI ... | KIES PETER | CFO | Option Exercise | M | 0.00 | 27,567 | 0 | 27,566 | |
Mar 09 2020 | GEB | INOVIO PHARMACEUTI ... | KIES PETER | CFO | Payment of Exercise | F | 14.09 | 7,424 | 104,604 | 140,923 | 148.3 K to 140.9 K (-5.00 %) |
Mar 09 2020 | GEB | INOVIO PHARMACEUTI ... | KIES PETER | CFO | Buy | M | 0.00 | 21,467 | 0 | 148,347 | 126.9 K to 148.3 K (+16.92 %) |
Mar 09 2020 | GEB | INOVIO PHARMACEUTI ... | KIES PETER | CFO | Payment of Exercise | F | 9.80 | 9,817 | 96,207 | 126,880 | 136.7 K to 126.9 K (-7.18 %) |
Mar 09 2020 | GEB | INOVIO PHARMACEUTI ... | KIES PETER | CFO | Buy | M | 0.00 | 27,567 | 0 | 136,697 | 109.1 K to 136.7 K (+25.26 %) |
Jan 16 2020 | GEB | INOVIO PHARMACEUTI ... | Shepard Jay | Director | Option Exercise | A | 3.35 | 20,000 | 67,000 | 20,000 | |
Jan 16 2020 | GEB | INOVIO PHARMACEUTI ... | Shepard Jay | Director | Option Exercise | A | 0.00 | 12,821 | 0 | 12,821 | |
Jan 13 2020 | GEB | INOVIO PHARMACEUTI ... | Kim Jong Joseph | Chief Executive Off ... | Buy | P | 3.11 | 22,500 | 69,975 | 1,100,707 | 1.1 M to 1.1 M (+2.09 %) |
Jan 06 2020 | GEB | INOVIO PHARMACEUTI ... | Zoth Lota S. | Director | Option Exercise | M | 0.00 | 4,090 | 0 | 8,180 | |
Jan 06 2020 | GEB | INOVIO PHARMACEUTI ... | Zoth Lota S. | Director | Buy | M | 0.00 | 4,090 | 0 | 4,090 | 0 to 4.1 K |
Dec 05 2019 | GEB | INOVIO PHARMACEUTI ... | YARNO WENDY L | Director | Option Exercise | M | 0.00 | 4,090 | 0 | 4,090 | |
Dec 05 2019 | GEB | INOVIO PHARMACEUTI ... | YARNO WENDY L | Director | Buy | M | 0.00 | 4,090 | 0 | 16,350 | 12.3 K to 16.4 K (+33.36 %) |
Sep 04 2019 | GEB | INOVIO PHARMACEUTI ... | Humeau Laurent | Chief Scientific Of ... | Buy | P | 2.22 | 4,500 | 9,990 | 50,333 | 45.8 K to 50.3 K (+9.82 %) |
Aug 02 2019 | GEB | INOVIO PHARMACEUTI ... | Weiner David B. | Director | Sell | S | 2.72 | 16,352 | 44,477 | 797,110 | 813.5 K to 797.1 K (-2.01 %) |
Jun 05 2019 | GEB | INOVIO PHARMACEUTI ... | Humeau Laurent | Chief Scientific Of ... | Buy | P | 2.50 | 20,000 | 50,000 | 45,833 | 25.8 K to 45.8 K (+77.42 %) |
Jun 04 2019 | GEB | INOVIO PHARMACEUTI ... | Kim Jong Joseph | Chief Executive Off ... | Sell | S | 2.31 | 296,705 | 684,736 | 816,527 | 1.1 M to 816.5 K (-26.65 %) |
Jun 04 2019 | GEB | INOVIO PHARMACEUTI ... | Kim Jong Joseph | Chief Executive Off ... | Sell | S | 2.40 | 500,000 | 1,200,800 | 1,113,232 | 1.6 M to 1.1 M (-30.99 %) |
Jun 04 2019 | GEB | INOVIO PHARMACEUTI ... | Kim Jong Joseph | Chief Executive Off ... | Sell | S | 2.30 | 832,848 | 1,914,468 | 1,078,207 | 1.9 M to 1.1 M (-43.58 %) |
Jun 04 2019 | GEB | INOVIO PHARMACEUTI ... | Kim Jong Joseph | Chief Executive Off ... | Sell | S | 2.44 | 500,000 | 1,217,650 | 1,911,055 | 2.4 M to 1.9 M (-20.74 %) |
May 23 2019 | GEB | INOVIO PHARMACEUTI ... | Kim Jong Joseph | Chief Executive Off ... | Sell | S | 3.31 | 100,000 | 331,000 | 2,411,055 | 2.5 M to 2.4 M (-3.98 %) |
May 17 2019 | GEB | INOVIO PHARMACEUTI ... | Kim Jong Joseph | Chief Executive Off ... | Sell | S | 3.50 | 61,212 | 214,242 | 1,613,232 | 1.7 M to 1.6 M (-3.66 %) |
May 17 2019 | GEB | INOVIO PHARMACEUTI ... | Kim Jong Joseph | Chief Executive Off ... | Sell | S | 3.50 | 75,556 | 264,446 | 1,674,444 | 1.8 M to 1.7 M (-4.32 %) |
May 17 2019 | GEB | INOVIO PHARMACEUTI ... | Kim Jong Joseph | Chief Executive Off ... | Sell | S | 3.50 | 61,212 | 214,242 | 1,613,232 | 1.7 M to 1.6 M (-3.66 %) |
May 17 2019 | GEB | INOVIO PHARMACEUTI ... | Kim Jong Joseph | Chief Executive Off ... | Sell | S | 3.50 | 75,556 | 264,446 | 1,674,444 | 1.8 M to 1.7 M (-4.32 %) |
May 13 2019 | GEB | INOVIO PHARMACEUTI ... | YARNO WENDY L | Director | Option Exercise | M | 0.00 | 8,170 | 0 | 0 | |
May 13 2019 | GEB | INOVIO PHARMACEUTI ... | YARNO WENDY L | Director | Buy | M | 0.00 | 8,170 | 0 | 12,260 | 4.1 K to 12.3 K (+199.76 %) |
May 13 2019 | GEB | INOVIO PHARMACEUTI ... | BENITO SIMON X | Director | Option Exercise | M | 0.00 | 8,170 | 0 | 0 | |
May 13 2019 | GEB | INOVIO PHARMACEUTI ... | BENITO SIMON X | Director | Buy | M | 0.00 | 8,170 | 0 | 43,637 | 35.5 K to 43.6 K (+23.04 %) |
May 13 2019 | GEB | INOVIO PHARMACEUTI ... | Cabrera Angel | Director | Option Exercise | M | 0.00 | 8,170 | 0 | 0 | |
May 13 2019 | GEB | INOVIO PHARMACEUTI ... | Cabrera Angel | Director | Buy | M | 0.00 | 8,170 | 0 | 67,589 | 59.4 K to 67.6 K (+13.75 %) |
May 13 2019 | GEB | INOVIO PHARMACEUTI ... | Weiner David B. | Director | Option Exercise | M | 0.00 | 8,170 | 0 | 0 | |
May 13 2019 | GEB | INOVIO PHARMACEUTI ... | Weiner David B. | Director | Buy | M | 0.00 | 8,170 | 0 | 813,462 | 805.3 K to 813.5 K (+1.01 %) |
May 13 2019 | GEB | INOVIO PHARMACEUTI ... | COLLINS MORTON | Director | Option Exercise | M | 0.00 | 8,170 | 0 | 0 | |
May 13 2019 | GEB | INOVIO PHARMACEUTI ... | COLLINS MORTON | Director | Buy | M | 0.00 | 8,170 | 0 | 168,130 | 160 K to 168.1 K (+5.11 %) |
May 09 2019 | GEB | INOVIO PHARMACEUTI ... | Zoth Lota S. | Director | Option Exercise | A | 0.00 | 8,013 | 0 | 8,013 | |
May 09 2019 | GEB | INOVIO PHARMACEUTI ... | Zoth Lota S. | Director | Option Exercise | A | 3.90 | 12,500 | 48,750 | 12,500 | |
May 09 2019 | GEB | INOVIO PHARMACEUTI ... | Miller Ann Calby | Director | Option Exercise | A | 0.00 | 8,013 | 0 | 8,013 | |
May 09 2019 | GEB | INOVIO PHARMACEUTI ... | Miller Ann Calby | Director | Option Exercise | A | 3.90 | 12,500 | 48,750 | 12,500 | |
May 09 2019 | GEB | INOVIO PHARMACEUTI ... | COLLINS MORTON | Director | Option Exercise | A | 0.00 | 8,013 | 0 | 8,013 | |
May 09 2019 | GEB | INOVIO PHARMACEUTI ... | COLLINS MORTON | Director | Option Exercise | A | 3.90 | 12,500 | 48,750 | 12,500 | |
May 09 2019 | GEB | INOVIO PHARMACEUTI ... | BENITO SIMON X | Director | Option Exercise | A | 0.00 | 8,013 | 0 | 8,013 | |
May 09 2019 | GEB | INOVIO PHARMACEUTI ... | BENITO SIMON X | Director | Option Exercise | A | 3.90 | 12,500 | 48,750 | 12,500 | |
May 09 2019 | GEB | INOVIO PHARMACEUTI ... | YARNO WENDY L | Director | Option Exercise | A | 0.00 | 8,013 | 0 | 8,013 | |
May 09 2019 | GEB | INOVIO PHARMACEUTI ... | YARNO WENDY L | Director | Option Exercise | A | 3.90 | 12,500 | 48,750 | 12,500 | |
May 09 2019 | GEB | INOVIO PHARMACEUTI ... | Cabrera Angel | Director | Option Exercise | A | 0.00 | 8,013 | 0 | 8,013 | |
May 09 2019 | GEB | INOVIO PHARMACEUTI ... | Cabrera Angel | Director | Option Exercise | A | 3.90 | 12,500 | 48,750 | 12,500 | |
May 09 2019 | GEB | INOVIO PHARMACEUTI ... | Weiner David B. | Director | Option Exercise | A | 0.00 | 8,013 | 0 | 8,013 | |
May 09 2019 | GEB | INOVIO PHARMACEUTI ... | Weiner David B. | Director | Option Exercise | A | 3.90 | 12,500 | 48,750 | 12,500 | |
Mar 27 2019 | GEB | INOVIO PHARMACEUTI ... | Shea Jacqueline Elizabeth | Chief Operating Off ... | Option Exercise | A | 3.62 | 200,000 | 724,000 | 200,000 | |
Mar 27 2019 | GEB | INOVIO PHARMACEUTI ... | Shea Jacqueline Elizabeth | Chief Operating Off ... | Option Exercise | A | 0.00 | 50,000 | 0 | 50,000 | |
Mar 25 2019 | GEB | INOVIO PHARMACEUTI ... | Miller Ann Calby | Director | Option Exercise | A | 3.72 | 20,000 | 74,400 | 20,000 | |
Mar 25 2019 | GEB | INOVIO PHARMACEUTI ... | Miller Ann Calby | Director | Option Exercise | A | 0.00 | 12,821 | 0 | 12,821 | |
Mar 12 2019 | GEB | INOVIO PHARMACEUTI ... | Humeau Laurent | Chief Scientific Of ... | Option Exercise | A | 0.00 | 59,700 | 0 | 59,700 | |
Mar 12 2019 | GEB | INOVIO PHARMACEUTI ... | Humeau Laurent | Chief Scientific Of ... | Option Exercise | A | 3.34 | 93,200 | 311,288 | 93,200 | |
Mar 12 2019 | GEB | INOVIO PHARMACEUTI ... | Humeau Laurent | Chief Scientific Of ... | Option Exercise | M | 0.00 | 2,812 | 0 | 2,812 | |
Mar 12 2019 | GEB | INOVIO PHARMACEUTI ... | Humeau Laurent | Chief Scientific Of ... | Option Exercise | M | 0.00 | 2,666 | 0 | 0 | |
Mar 12 2019 | GEB | INOVIO PHARMACEUTI ... | Humeau Laurent | Chief Scientific Of ... | Payment of Exercise | F | 3.34 | 948 | 3,166 | 25,833 | 26.8 K to 25.8 K (-3.54 %) |
Mar 12 2019 | GEB | INOVIO PHARMACEUTI ... | Humeau Laurent | Chief Scientific Of ... | Buy | M | 0.00 | 2,812 | 0 | 26,781 | 24 K to 26.8 K (+11.73 %) |
Mar 12 2019 | GEB | INOVIO PHARMACEUTI ... | Humeau Laurent | Chief Scientific Of ... | Payment of Exercise | F | 3.34 | 898 | 2,999 | 23,969 | 24.9 K to 24 K (-3.61 %) |
Mar 12 2019 | GEB | INOVIO PHARMACEUTI ... | Humeau Laurent | Chief Scientific Of ... | Buy | M | 0.00 | 2,666 | 0 | 24,867 | 22.2 K to 24.9 K (+12.01 %) |
Mar 12 2019 | GEB | INOVIO PHARMACEUTI ... | Kim Jong Joseph | Chief Executive Off ... | Option Exercise | A | 0.00 | 191,100 | 0 | 191,100 | |
Mar 12 2019 | GEB | INOVIO PHARMACEUTI ... | Kim Jong Joseph | Chief Executive Off ... | Option Exercise | A | 3.34 | 298,100 | 995,654 | 298,100 | |
Mar 12 2019 | GEB | INOVIO PHARMACEUTI ... | Kim Jong Joseph | Chief Executive Off ... | Option Exercise | M | 0.00 | 105,700 | 0 | 105,700 | |
Mar 12 2019 | GEB | INOVIO PHARMACEUTI ... | Kim Jong Joseph | Chief Executive Off ... | Option Exercise | M | 0.00 | 57,333 | 0 | 0 | |
Mar 12 2019 | GEB | INOVIO PHARMACEUTI ... | Kim Jong Joseph | Chief Executive Off ... | Payment of Exercise | F | 3.34 | 30,104 | 100,547 | 2,511,055 | 2.5 M to 2.5 M (-1.18 %) |
Mar 12 2019 | GEB | INOVIO PHARMACEUTI ... | Kim Jong Joseph | Chief Executive Off ... | Buy | M | 0.00 | 105,700 | 0 | 2,541,159 | 2.4 M to 2.5 M (+4.34 %) |
Mar 12 2019 | GEB | INOVIO PHARMACEUTI ... | Kim Jong Joseph | Chief Executive Off ... | Payment of Exercise | F | 3.34 | 16,329 | 54,539 | 2,435,459 | 2.5 M to 2.4 M (-0.67 %) |
Mar 12 2019 | GEB | INOVIO PHARMACEUTI ... | Kim Jong Joseph | Chief Executive Off ... | Buy | M | 0.00 | 57,333 | 0 | 2,451,788 | 2.4 M to 2.5 M (+2.39 %) |
Mar 12 2019 | GEB | INOVIO PHARMACEUTI ... | KIES PETER | CFO | Option Exercise | A | 0.00 | 64,400 | 0 | 64,400 | |
Mar 12 2019 | GEB | INOVIO PHARMACEUTI ... | KIES PETER | CFO | Option Exercise | A | 3.34 | 100,500 | 335,670 | 100,500 | |
Mar 12 2019 | GEB | INOVIO PHARMACEUTI ... | KIES PETER | CFO | Option Exercise | M | 0.00 | 20,433 | 0 | 20,433 | |
Mar 12 2019 | GEB | INOVIO PHARMACEUTI ... | KIES PETER | CFO | Option Exercise | M | 0.00 | 25,000 | 0 | 0 | |
Mar 12 2019 | GEB | INOVIO PHARMACEUTI ... | KIES PETER | CFO | Payment of Exercise | F | 3.34 | 7,066 | 23,600 | 109,130 | 116.2 K to 109.1 K (-6.08 %) |
Mar 12 2019 | GEB | INOVIO PHARMACEUTI ... | KIES PETER | CFO | Buy | M | 0.00 | 20,433 | 0 | 116,196 | 95.8 K to 116.2 K (+21.34 %) |
Mar 12 2019 | GEB | INOVIO PHARMACEUTI ... | KIES PETER | CFO | Payment of Exercise | F | 3.34 | 8,591 | 28,694 | 95,763 | 104.4 K to 95.8 K (-8.23 %) |
Mar 12 2019 | GEB | INOVIO PHARMACEUTI ... | KIES PETER | CFO | Buy | M | 0.00 | 25,000 | 0 | 104,354 | 79.4 K to 104.4 K (+31.50 %) |
Mar 12 2019 | GEB | INOVIO PHARMACEUTI ... | Weiner David B. | Director | Option Exercise | A | 0.00 | 35,000 | 0 | 35,000 | |
Mar 12 2019 | GEB | INOVIO PHARMACEUTI ... | Weiner David B. | Director | Option Exercise | A | 3.34 | 60,000 | 200,400 | 60,000 | |
Mar 12 2019 | GEB | INOVIO PHARMACEUTI ... | Weiner David B. | Director | Option Exercise | M | 0.00 | 11,667 | 0 | 11,666 | |
Mar 12 2019 | GEB | INOVIO PHARMACEUTI ... | Weiner David B. | Director | Option Exercise | M | 0.00 | 10,000 | 0 | 0 | |
Mar 12 2019 | GEB | INOVIO PHARMACEUTI ... | Weiner David B. | Director | Option Exercise | M | 0.00 | 5,333 | 0 | 0 | |
Mar 12 2019 | GEB | INOVIO PHARMACEUTI ... | Weiner David B. | Director | Buy | M | 0.00 | 11,667 | 0 | 805,292 | 793.6 K to 805.3 K (+1.47 %) |
Mar 12 2019 | GEB | INOVIO PHARMACEUTI ... | Weiner David B. | Director | Buy | M | 0.00 | 10,000 | 0 | 793,625 | 783.6 K to 793.6 K (+1.28 %) |
Mar 12 2019 | GEB | INOVIO PHARMACEUTI ... | Weiner David B. | Director | Buy | M | 0.00 | 5,333 | 0 | 783,625 | 778.3 K to 783.6 K (+0.69 %) |
Mar 07 2019 | GEB | INOVIO PHARMACEUTI ... | Bagarazzi Mark | Chief Medical Offic ... | Option Exercise | M | 0.00 | 27,567 | 0 | 55,133 | |
Mar 07 2019 | GEB | INOVIO PHARMACEUTI ... | Bagarazzi Mark | Chief Medical Offic ... | Payment of Exercise | F | 3.61 | 8,408 | 30,353 | 100,672 | 109.1 K to 100.7 K (-7.71 %) |
Mar 07 2019 | GEB | INOVIO PHARMACEUTI ... | Bagarazzi Mark | Chief Medical Offic ... | Buy | M | 0.00 | 27,567 | 0 | 109,080 | 81.5 K to 109.1 K (+33.82 %) |
Mar 07 2019 | GEB | INOVIO PHARMACEUTI ... | Weiner David B. | Director | Option Exercise | M | 0.00 | 11,667 | 0 | 23,333 | |
Mar 07 2019 | GEB | INOVIO PHARMACEUTI ... | Weiner David B. | Director | Buy | M | 0.00 | 11,667 | 0 | 778,292 | 766.6 K to 778.3 K (+1.52 %) |
Mar 07 2019 | GEB | INOVIO PHARMACEUTI ... | Kim Jong Joseph | Chief Executive Off ... | Option Exercise | M | 0.00 | 120,100 | 0 | 240,200 | |
Mar 07 2019 | GEB | INOVIO PHARMACEUTI ... | Kim Jong Joseph | Chief Executive Off ... | Payment of Exercise | F | 3.61 | 34,139 | 123,242 | 2,394,455 | 2.4 M to 2.4 M (-1.41 %) |
Mar 07 2019 | GEB | INOVIO PHARMACEUTI ... | Kim Jong Joseph | Chief Executive Off ... | Buy | M | 0.00 | 120,100 | 0 | 2,428,594 | 2.3 M to 2.4 M (+5.20 %) |
Mar 07 2019 | GEB | INOVIO PHARMACEUTI ... | KIES PETER | CFO | Option Exercise | M | 0.00 | 27,567 | 0 | 55,133 | |
Mar 07 2019 | GEB | INOVIO PHARMACEUTI ... | KIES PETER | CFO | Payment of Exercise | F | 3.61 | 10,301 | 37,187 | 79,354 | 89.7 K to 79.4 K (-11.49 %) |
Mar 07 2019 | GEB | INOVIO PHARMACEUTI ... | KIES PETER | CFO | Buy | M | 0.00 | 27,567 | 0 | 89,655 | 62.1 K to 89.7 K (+44.40 %) |
Jan 04 2019 | GEB | INOVIO PHARMACEUTI ... | Zoth Lota S. | Director | Option Exercise | A | 0.00 | 12,270 | 0 | 12,270 | |
Jan 04 2019 | GEB | INOVIO PHARMACEUTI ... | Zoth Lota S. | Director | Option Exercise | A | 4.28 | 20,000 | 85,600 | 20,000 | |
Dec 06 2018 | GEB | INOVIO PHARMACEUTI ... | DHILLON AVTAR S | Director | Option Exercise | M | 2.00 | 25,000 | 50,000 | 0 | |
Dec 06 2018 | GEB | INOVIO PHARMACEUTI ... | DHILLON AVTAR S | Director | Buy | M | 2.00 | 25,000 | 50,000 | 106,002 | 81 K to 106 K (+30.86 %) |
Dec 06 2018 | GEB | INOVIO PHARMACEUTI ... | YARNO WENDY L | Director | Option Exercise | M | 0.00 | 4,090 | 0 | 8,180 | |
Dec 06 2018 | GEB | INOVIO PHARMACEUTI ... | YARNO WENDY L | Director | Buy | M | 0.00 | 4,090 | 0 | 4,090 | 0 to 4.1 K |
Nov 30 2018 | GEB | INOVIO PHARMACEUTI ... | KIES PETER | CFO | Option Exercise | M | 2.00 | 10,001 | 20,002 | 0 | |
Nov 30 2018 | GEB | INOVIO PHARMACEUTI ... | KIES PETER | CFO | Sell | S | 5.28 | 10,001 | 52,805 | 62,088 | 72.1 K to 62.1 K (-13.87 %) |
Nov 30 2018 | GEB | INOVIO PHARMACEUTI ... | KIES PETER | CFO | Buy | M | 2.00 | 10,001 | 20,002 | 72,089 | 62.1 K to 72.1 K (+16.11 %) |
Sep 14 2018 | GEB | INOVIO PHARMACEUTI ... | Kim Jong Joseph | Chief Executive Off ... | Option Exercise | M | 5.08 | 49,060 | 249,225 | 0 | |
Sep 14 2018 | GEB | INOVIO PHARMACEUTI ... | Kim Jong Joseph | Chief Executive Off ... | Sell | S | 5.37 | 49,060 | 263,452 | 2,308,494 | 2.4 M to 2.3 M (-2.08 %) |
Sep 14 2018 | GEB | INOVIO PHARMACEUTI ... | Kim Jong Joseph | Chief Executive Off ... | Buy | M | 5.08 | 49,060 | 249,225 | 2,357,554 | 2.3 M to 2.4 M (+2.13 %) |
Jul 11 2018 | GEB | INOVIO PHARMACEUTI ... | KIES PETER | CFO | Option Exercise | M | 4.24 | 15,000 | 63,600 | 0 | |
Jul 11 2018 | GEB | INOVIO PHARMACEUTI ... | KIES PETER | CFO | Sell | S | 4.45 | 10,000 | 44,500 | 62,088 | 72.1 K to 62.1 K (-13.87 %) |
Jul 11 2018 | GEB | INOVIO PHARMACEUTI ... | KIES PETER | CFO | Sell | S | 4.43 | 25,000 | 110,750 | 72,088 | 97.1 K to 72.1 K (-25.75 %) |
Jul 11 2018 | GEB | INOVIO PHARMACEUTI ... | KIES PETER | CFO | Buy | M | 4.24 | 15,000 | 63,600 | 97,088 | 82.1 K to 97.1 K (+18.27 %) |
May 14 2018 | GEB | INOVIO PHARMACEUTI ... | Weiner David B. | Director | Option Exercise | M | 0.00 | 7,669 | 0 | 0 | |
May 14 2018 | GEB | INOVIO PHARMACEUTI ... | Weiner David B. | Director | Option Exercise | A | 0.00 | 8,170 | 0 | 8,170 |